Lypsa Gems (LYPSAGEMS)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹4.63 |
| Market Cap | ₹13.65 Cr |
| P/E Ratio | 7.85 |
| ROCE | -45.08% |
| ROE | 9.99% |
| Dividend Yield | 0% |
| Profit Growth | 1,000% |
| Debt/Equity | 0.79 |
| Sales Growth | -72.5% |
| Promoter Holding | 36.37% |
| 52-Week Range | ₹4.1 — ₹7.49 |
| Sector | Consumer Durables |
| Book Value | ₹6.29 |
Strengths
- Trades at 0.52x book value, with stated book value of ₹10.52 per share against a price of ₹5.49.
- Latest quarter shows a net profit of ₹1 Cr on sales of ₹5 Cr, indicating some operating pulse.
- Piotroski F-Score of 5/9 suggests the financial position is not completely deteriorating.
- Market cap of ₹15 Cr versus quarterly sales of ₹5 Cr implies a low revenue multiple if sales can stabilise.
Concerns
- ROE of -43.70% and ROCE of -45.08% show significant value destruction.
- Sales are declining at -21.75%, with no growth momentum.
- Trailing P/E of 0.00 and zero dividend yield mean no current earnings support or income return.
- Promoter holding of only 36.37% is low for a microcap, raising alignment and governance concerns.
AI Analysis
Lypsa Gems is the sort of stock that catches my eye only because the price is ₹5.49 against a book value of ₹10.52 — a rupee of assets for fifty paise. But as Ben Graham warned, a bargain can be a mirage if the assets cannot earn. The business returns are deeply negative: ROE is -43.70% and ROCE is -45.08%. That means the company is destroying capital, not compounding it. Sales fell 21.75% in the latest reported period, so there is no growth momentum. The trailing P/E of 0.00 tells me there is no meaningful earnings stream to justify a valuation. Yes, the latest quarter shows ₹5 Cr of sales and ₹1 Cr of net profit, and reported profit growth of 1000%, but one quarter does not make an investment. I need to see a consistent pattern, because these numbers can be seasonally distorted in gems and jewellery. Promoter holding of only 36.37% also bothers me; when insiders own a small piece of the company, I question how aligned their interests are with mine. There is no dividend, so I am not paid to wait. The Piotroski score of 5/9 is mediocre, not the 8 or 9 I expect for a financially improving firm. At a market cap of ₹15 Cr, this is a microcap with thin liquidity and little room for error. If management can convert the quarterly profit into sustained earnings, improve returns on equity and capital, and stabilise sales, then the discount to book may close. But I am not willing to assume that will happen. Buying a company that loses money just because it looks cheap is not investing; it is hoping. I would rather miss this opportunity than lose capital waiting for a turnaround that may never come.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer